Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

Clinical trial NCT05194735 · TERMINATED

Trial details

NCT number: NCT05194735
Sponsor: Alaunos Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gynecologic Cancer Colorectal Cancer Pancreatic Cancer Non-small Cell Lung Cancer Cholangiocarcinoma Ovarian Cancer Endometrial Cancer Ovarian Carcinoma Ovary Neoplasm Squamous Cell Lung Cancer Adenocarcinoma of Lung Adenosquamous Cell Lung Cancer

Start date: 2022-04-04
Primary completion: 2023-08-14
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.